SCHEMBL480171

SCHEMBL480171

Cc1[nH]c(=O)ccc1C(O)(C(C)c1ccc(Oc2ccc(C#N)cc2F)cc1Cl)C(F)(F)F

nearest known ligand 0.35

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 1/20 0.35
HTR2A P28223 2/20 0.34
KCNH2 Q12809 2/20 0.34
SLC6A4 P31645 1/20 0.34
AR P10275 5/20 0.33
NR3C1 P04150 2/20 0.32
PGR P06401 2/20 0.32
NR3C2 P08235 2/20 0.32
FFAR1 O14842 1/20 0.32
TBXA2R P21731 2/20 0.31
SLC22A12 Q96S37 2/20 0.31
SCN9A Q15858 1/20 0.31
EPAS1 Q99814 1/20 0.31
GPR119 Q8TDV5 1/20 0.30
PDK1 Q15118 1/20 0.30
PDK2 Q15119 1/20 0.30
PDK3 Q15120 1/20 0.30
PDK4 Q16654 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL479955 0.86 IGFBP3 (0.35)
SCHEMBL479869 0.82 CYP11B1 (0.35) CYP11B1HTR2AKCNH2SLC6A4AR
SCHEMBL481056 0.80 CYP11B1 (0.36) CYP11B1HTR2AKCNH2SLC6A4AR
SCHEMBL15789678 0.79 MCL1 (0.35) FFAR1
SCHEMBL733559 0.79 CYP11B1 (0.38) CYP11B1HTR2AKCNH2SLC6A4AR
SCHEMBL480172 0.78 NR3C1 (0.34) ARNR3C1PGRNR3C2FFAR1
SCHEMBL480155 0.78 SCN8A (0.36) SCN9A
SCHEMBL480320 0.78 SCN9A (0.34) SCN9A
SCHEMBL474548 0.77 AR (0.35) CYP11B1HTR2AKCNH2SLC6A4AR
SCHEMBL480110 0.77 SLC22A12 (0.37) CYP11B1HTR2AKCNH2SLC6A4AR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2411361-A1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS F. Hoffmann-La Roche AG (CH) 2012-02-01 EP disclosed
WO-2010108902-A1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2010-09-30 WO disclosed